Figures & data
Table 1. Parameters for estimating the clinical severity of poisoning.
Table 1. Impact of changes in UK management advice for paracetamol overdose on the numbers of adult patients admitted and treated in Newcastle upon Tyne.
Table 1. Exposures to a dietary supplement.
Table 1. Comparison of unit dose and non-unit dose pediatric laundry detergent exposures.
Table 1. Percentages of exposures by substance categories most frequently identified by the US and the Italian systems.
Table 1. Severity of non-occupational and occupational exposures.
Table 1. Baseline characteristics in RAVE-I and RAVE-II.
Table 1. Pilot study comparing hemodynamic measures and survival in swine anesthetized with AC and isoflurane.
Table 1. Top brand names of synthetic cannabinoid exposures reported to NSW Poisons Information Centre (N = 180).
Table 1. Percentage of MSM who had heard of/misused the drugs.
Table 1. The most commonly used drugs and combinations.
Table 1. Frequency of detection of CYP inhibitor medications and methadone in postmortem examinations.
Table 1. Treatment of mercury poisoning with chelating agents.
Table 1. Reported cases of aconite-induced ventricular dysrythmia.
Table 1. Adverse effects and responsible plants, survey in diabetics, Morocco, 2013.
Table 1. Dental paracetamol enquiries to the NPIS pre- and post-MHRA guidance change.
Table 1. ECG predictors of ACVE in ED ADO patients.
Table 1. Demographics and triage categories.
Table 1. Monitoring of respiratory frequency and urinary pH in the Tasiilaq methanol poisoning case.
Table 1. Dose ingested, severity, and outcome.
Table 1. Symptoms and signs observed in the 59 included animals (cats and dogs).
Table 1. Culprit herbs, other herbs implicated, pattern of liver injury, and the possible hepatotoxic constituents causing liver injury.